Impact of continuous glucose monitoring on glycemic control and biochemical cardiovascular risk factors in kidney transplant recipients with type 1 diabetes
Clicks: 1
ID: 323248
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #43 of 94 articles by views in nephrology dialysis transplantation
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Aims To compare biochemical risk factors for cardiovascular disease (CVD) in kidney transplant recipients (KTx) with type 1 diabetes (T1D) who used continuous glucose monitoring (CGM) devices or underwent simultaneous kidney and pancreas (SPK) transplantation during long-term follow-up. Materials and methods 22 graft recipients with T1D using CGM (KTx CGM) and 22 patients with T1D after SPK were included in the study. Study groups were matched for age and diabetes duration at the time of transplantation, age at the time of the study, sex, body mass index (BMI), total duration of dialysis therapy, dialysis modality, pretransplant CVD, and rates of kidney re-transplantation. Biochemical markers of glycemic control and risk for CVD were assessed over a 9-11 year follow up period. Results Fasting plasma glucose (FPG) and HbA1c were higher in the KTx CGM versus SPK group (6.5 [4.9; 7.8] vs 4.7 [4.4; 5.6] mmol/L, p<0.01, and 6.7 [5.9; 7.5] vs 5.2 [5.1; 5.4]%, p<0.001, respectively). Total cholesterol (TC) and high-density lipoprotein (HDL) did not differ between groups. Low-density lipoprotein (LDL) concentrations were lower in the KTx CGM vs the SPK group (2.35 ± 0.66 vs 2.96 ± 1.13 mmol/L, p=0.056). Triglyceride values were higher in the KTx CGM vs SPK group (1.29 ± 0.45 mmol/L vs 1.02 ± 0.39 mmo/L, p<0.05). Serum creatinine was higher (122.7 μmol/L vs 87.2 μmol/L, p< 0.01), and estimated glomerular filtration rates (eGFR) were lower (73.8 ± 25.0 vs 51.3 ± 18.6 ml/min.1.73 m2, p< 0.01) in the KTx CGM vs the SPK group. Conclusions Application of CGM technology in kidney graft recipients with T1D enabled good control of glucose levels and allowed for normalization of a number of biochemical risk factors for CVD. Pancreas transplantation remains the optimal procedure in achieving physiological blood glucose levels in T1D kidney recipients.
| Reference Key |
openalex_W7172339569
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Monika Widera, Aureliusz Kolonko, Aureliusz Kolonko, Dorota Kamińska, Robert Świder, Robert Król, Sylwia Sekta, Andrzej Więcek, Jacek Ziaja |
| Journal | nephrology dialysis transplantation |
| Year | 2026 |
| DOI |
10.1093/ndt/gfag168
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.